Cargando…
Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis
BACKGROUND: Most patients with chronic obstructive pulmonary disease (COPD) receive inhaled long-acting bronchodilators and inhaled corticosteroids. Conventional meta-analyses established that these drugs reduce COPD exacerbations when separately compared with placebo. However, there are relatively...
Autores principales: | Puhan, Milo A, Bachmann, Lucas M, Kleijnen, Jos, ter Riet, Gerben, Kessels, Alphons G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2636836/ https://www.ncbi.nlm.nih.gov/pubmed/19144173 http://dx.doi.org/10.1186/1741-7015-7-2 |
Ejemplares similares
-
Where is the supporting evidence for treating mild to moderate chronic obstructive pulmonary disease exacerbations with antibiotics? A systematic review
por: Puhan, Milo A, et al.
Publicado: (2008) -
Physical activity and risk of comorbidities in patients with chronic obstructive pulmonary disease: a cohort study
por: Yu, Tsung, et al.
Publicado: (2017) -
Doxycycline for exacerbations of chronic obstructive pulmonary disease in outpatients: who benefits?
por: van Velzen, Patricia, et al.
Publicado: (2020) -
ICE COLD ERIC – International collaborative effort on chronic obstructive lung disease: exacerbation risk index cohorts – Study protocol for an international COPD cohort study
por: Siebeling, Lara, et al.
Publicado: (2009) -
Prediction of long-term clinical outcomes using simple functional exercise performance tests in patients with COPD: a 5-year prospective cohort study
por: Crook, Sarah, et al.
Publicado: (2017)